Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buyang Huanwu decoction-type formulas for stable angina in coronary heart disease
ChiCTR1800015191Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Aug 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of naoxintong and Buyang Huanwu granules in coronary arteriosclerosis and stable angina, sponsored by The Second Affiliated Hospital of Zhejiang Chinese Medical University. Started Aug 2017; status: recruiting.
02
Drugs
naoxintongBuyang Huanwu granules
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR1800015191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015191.